SUPNSupernus Pharmaceuticals, Inc.

$44.93

Who owns SUPN

320 institutions reported holding SUPN for 2026Q1, together 101% of the company, fewer than the 327 a quarter earlier.

320

Institutions reporting a position · as of 2026Q1 · down from 327 the quarter before

Shares held by institutions
58.2M

Shares held by institutions · 101% of the company · long US equity positions only, as reported on Form 13F

Reported value
$3.00B

Reported value · at 2026-03-31 prices, not today's

Top 5 holders
40%

Top 5 holders · of the whole company, between five filers

Details
Reporting quarter2026-03-31
2026Q1
Quarters on record
52
New positions
36
Positions exited
49
Added to
105
Reduced
105
Top 10 holdersof the company
55%
Institutional ownership by quarter, 2013Q2 to 2026Q1
QuarterFilersSharesReported value
2026Q132058.2M$3.00B
2025Q432757.1M$2.84B
2025Q330657.6M$2.75B
2025Q228959.5M$1.87B
2025Q129159.2M$1.94B
2024Q429059.5M$2.15B
2024Q327059.9M$1.87B
2024Q224258.4M$1.56B
2024Q124856.7M$1.93B
2023Q424457.1M$1.65B
2023Q323657.0M$1.57B
2023Q224757.3M$1.72B
2023Q125455.7M$2.00B
2022Q426255.8M$1.99B
2022Q324255.6M$1.88B
2022Q222157.6M$1.63B
Largest reported holders, 2026Q1
HolderShares% of companyValue
BlackRock Inc.8.8M15%$455M
VANGUARD GROUP INC6.2M11%$319M
MILLENNIUM MANAGEMENT LLC3.3M5.8%$171M
DIMENSIONAL FUND ADVISORS LP2.3M4.0%$119M
STATE STREET CORP2.3M4.0%$118M
NOMURA HOLDINGS INC2.0M3.5%$105M
ARMISTICE CAPITAL, LLC1.9M3.3%$98M
RENAISSANCE TECHNOLOGIES LLC1.7M3.0%$88M
GEODE CAPITAL MANAGEMENT LLC1.6M2.8%$84M
CITADEL ADVISORS LLC1.5M2.6%$77M

SEC Form 13F data sets (DERA bulk files). 13F is quarterly, filed up to 45 days late, and covers long US equity positions only, no shorts, no derivatives, nothing held below the reporting threshold.

reading the register…